Financial support for this work was provided by the UK Biotechnology and Biological Sciences Research Council (BBSRC) Grant Number BB/1013245/1. The author has no other relevant affiliations or ...
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback